The new coronary vasodilators: calcium blockers

L. D. Hillis

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Citations (Scopus)

Abstract

Considerable clinical promise is being shown by a group of investigational drugs that inhibit the movement of calcium into cells, thereby reducing both coronary and systemic vascular resistance and depressing myocardial contractility. In studies conducted here and abroad, calcium blockers appear to reduce the frequency of both typical and variant angina attacks and limit the extent and severity of myocardial injury in acute infarctions. Some of these agents also combat supraventricular tachyarrhythmias and reduce blood pressure in patients with systemic arterial hypertension.

Original languageEnglish (US)
Title of host publicationJournal of Cardiovascular Medicine
Pages583-590
Number of pages8
Volume5
Edition6
StatePublished - 1980
Externally publishedYes

Fingerprint

Vasodilator Agents
Investigational Drugs
Calcium
Tachycardia
Vascular Resistance
Infarction
Blood Pressure
Hypertension
Wounds and Injuries

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Hillis, L. D. (1980). The new coronary vasodilators: calcium blockers. In Journal of Cardiovascular Medicine (6 ed., Vol. 5, pp. 583-590)

The new coronary vasodilators : calcium blockers. / Hillis, L. D.

Journal of Cardiovascular Medicine. Vol. 5 6. ed. 1980. p. 583-590.

Research output: Chapter in Book/Report/Conference proceedingChapter

Hillis, LD 1980, The new coronary vasodilators: calcium blockers. in Journal of Cardiovascular Medicine. 6 edn, vol. 5, pp. 583-590.
Hillis LD. The new coronary vasodilators: calcium blockers. In Journal of Cardiovascular Medicine. 6 ed. Vol. 5. 1980. p. 583-590
Hillis, L. D. / The new coronary vasodilators : calcium blockers. Journal of Cardiovascular Medicine. Vol. 5 6. ed. 1980. pp. 583-590
@inbook{28f06c53abc1445eb9d37d1247f43454,
title = "The new coronary vasodilators: calcium blockers",
abstract = "Considerable clinical promise is being shown by a group of investigational drugs that inhibit the movement of calcium into cells, thereby reducing both coronary and systemic vascular resistance and depressing myocardial contractility. In studies conducted here and abroad, calcium blockers appear to reduce the frequency of both typical and variant angina attacks and limit the extent and severity of myocardial injury in acute infarctions. Some of these agents also combat supraventricular tachyarrhythmias and reduce blood pressure in patients with systemic arterial hypertension.",
author = "Hillis, {L. D.}",
year = "1980",
language = "English (US)",
volume = "5",
pages = "583--590",
booktitle = "Journal of Cardiovascular Medicine",
edition = "6",

}

TY - CHAP

T1 - The new coronary vasodilators

T2 - calcium blockers

AU - Hillis, L. D.

PY - 1980

Y1 - 1980

N2 - Considerable clinical promise is being shown by a group of investigational drugs that inhibit the movement of calcium into cells, thereby reducing both coronary and systemic vascular resistance and depressing myocardial contractility. In studies conducted here and abroad, calcium blockers appear to reduce the frequency of both typical and variant angina attacks and limit the extent and severity of myocardial injury in acute infarctions. Some of these agents also combat supraventricular tachyarrhythmias and reduce blood pressure in patients with systemic arterial hypertension.

AB - Considerable clinical promise is being shown by a group of investigational drugs that inhibit the movement of calcium into cells, thereby reducing both coronary and systemic vascular resistance and depressing myocardial contractility. In studies conducted here and abroad, calcium blockers appear to reduce the frequency of both typical and variant angina attacks and limit the extent and severity of myocardial injury in acute infarctions. Some of these agents also combat supraventricular tachyarrhythmias and reduce blood pressure in patients with systemic arterial hypertension.

UR - http://www.scopus.com/inward/record.url?scp=0019304854&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019304854&partnerID=8YFLogxK

M3 - Chapter

AN - SCOPUS:0019304854

VL - 5

SP - 583

EP - 590

BT - Journal of Cardiovascular Medicine

ER -